Union Group’s, Will McElroy, discusses the state of the global mental health crisis and the revolutionary potential of psychedelic treatments with Biomind Lab’s CEO & Director, Alejandro Antalich, and Head Scientist & Clinical Advisor, Dr. Draulio Barros de Araujo.